Roche Targets Weight-Loss Drug Market Dominated by Novo Nordisk, Eli Lilly – Investopedia

Roche Targets Weight-Loss Drug Market Dominated by Novo Nordisk, Eli Lilly  Investopedia

Roche Further Boosts Obesity Pipeline With Zealand Pharma Deal Worth $5.3 Billion For Weight Loss Drugs – Benzinga

Roche Further Boosts Obesity Pipeline With Zealand Pharma Deal Worth $5.3 Billion For Weight Loss Drugs  Benzinga

How weight-loss drugs could help treat addiction, arthritis, more – TODAY

How weight-loss drugs could help treat addiction, arthritis, more  TODAY

What are the other health benefits weight-loss drugs may offer? – TODAY

What are the other health benefits weight-loss drugs may offer?  TODAY

Novo Nordisk, Lilly Stocks Are Falling. A Rival Weight-Loss Drug Is on the Way. – Barron’s

Novo Nordisk, Lilly Stocks Are Falling. A Rival Weight-Loss Drug Is on the Way.  Barron’s

How the New Weight Loss Medications Change Our Relationship With Food – Yale School of Medicine

How the New Weight Loss Medications Change Our Relationship With Food  Yale School of Medicine

How the New Weight Loss Medications Change Our Relationship With Food – Yale School of Medicine

How the New Weight Loss Medications Change Our Relationship With Food  Yale School of Medicine

More claimants interested in weight-loss drugs; few are covered in comp – Business Insurance

More claimants interested in weight-loss drugs; few are covered in comp  Business Insurance

Ekta Kapoor wonders about the best weight loss solution: ‘Ozempic, Mounjaro or anti-inflammatory diet’ – The Indian Express

Ekta Kapoor wonders about the best weight loss solution: ‘Ozempic, Mounjaro or anti-inflammatory diet’  The Indian Express

Zealand and Roche strike $5.3bn obesity treatment deal

The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in…